---
figid: PMC9315613__pharmaceuticals-15-00808-g002
figtitle: 'Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling
  Pathways: Evidence from In Vitro Studies'
organisms:
- Olea europaea
- Brassica oleracea
- Allium cepa
- Allium sativum
- Daucus carota
- Pyrus communis
- Catharanthus roseus
- Scutellaria baicalensis
- Salvia rosmarinus
- Silybum marianum
- Polygonum cuspidatum
- Momordica charantia
- Trifolium pratense
- Coptis chinensis
- Sophora flavescens
- Rheum rhabarbarum
- Humulus lupulus
- Andrographis paniculata
- Centella asiatica
- Lithospermum erythrorhizon
- Saussurea costus
- Spatholobus suberectus
- Passiflora caerulea
- Ganoderma sinense
- Carpesium abrotanoides
- Berberis asiatica
- Mundulea sericea
- Polygala flavescens
- Gnetum gnemonoides
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Homo sapiens
- Escherichia coli
- Chlorocebus aethiops
- Bacillus sp. in firmicutes
- Opsanus beta
- Betapolyomavirus macacae
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9315613
filename: pharmaceuticals-15-00808-g002.jpg
figlink: /pmc/articles/PMC9315613/figure/pharmaceuticals-15-00808-f002/
number: F2
caption: 'Simplified scheme of the energetic metabolism in cancer cells. Aerobic Glycolysis,
  Pentose Pyruvate Pathway, and TCA cycle. Natural compounds which inhibit the glycolytic
  pathway according to in vitro studies (the ligand-binding screening studies without
  in vitro testing were excluded): 1. Apigenin, 2. Berberine, 3. Bergapten, 4. Chrysin,
  5. Costunolide, 6. Daidzein, 7. Deguelin, 8. Dioscin, 9. Epigallocatechin, 10. Epigallocatechin
  gallate, 11. Galloflavin, 12. Genistein, 13. Gliotoxin, 14. Glucopiericidin A, 15.
  Kaempferol, 16. Oleanolic acid, 17. Oroxylin A, 18. Phloretin, 19. Pseurotin A,
  20. Prosapogenin A, 21. Quercetin, 22. Resveratrol, 23. Scutellarin, 24. Silybin,
  25. Shikonin, 26. Sulforaphane, 27. Wogonin, 28. Worenine, 29. Xanthohumol. The
  red-colored enzymes represent key regulators of the glycolytic pathway.'
papertitle: 'Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling
  Pathways: Evidence from In Vitro Studies.'
reftext: Ioana-Ecaterina Pralea, et al. Pharmaceuticals (Basel). 2022 Jul;15(7):808.
year: '2022'
doi: 10.3390/ph15070808
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords: phytochemicals | tumor glycolysis | tumor hypoxia | Warburg effect | HIF-1
  signaling pathway | metabolomics
automl_pathway: 0.8588573
figid_alias: PMC9315613__F2
figtype: Figure
redirect_from: /figures/PMC9315613__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9315613__pharmaceuticals-15-00808-g002.html
  '@type': Dataset
  description: 'Simplified scheme of the energetic metabolism in cancer cells. Aerobic
    Glycolysis, Pentose Pyruvate Pathway, and TCA cycle. Natural compounds which inhibit
    the glycolytic pathway according to in vitro studies (the ligand-binding screening
    studies without in vitro testing were excluded): 1. Apigenin, 2. Berberine, 3.
    Bergapten, 4. Chrysin, 5. Costunolide, 6. Daidzein, 7. Deguelin, 8. Dioscin, 9.
    Epigallocatechin, 10. Epigallocatechin gallate, 11. Galloflavin, 12. Genistein,
    13. Gliotoxin, 14. Glucopiericidin A, 15. Kaempferol, 16. Oleanolic acid, 17.
    Oroxylin A, 18. Phloretin, 19. Pseurotin A, 20. Prosapogenin A, 21. Quercetin,
    22. Resveratrol, 23. Scutellarin, 24. Silybin, 25. Shikonin, 26. Sulforaphane,
    27. Wogonin, 28. Worenine, 29. Xanthohumol. The red-colored enzymes represent
    key regulators of the glycolytic pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A1
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - PFKM
  - LDHA
  - LDHB
  - LDHC
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - CycE
  - cyc
  - Ald1
  - Gapdh2
  - Gapdh1
  - Glut1
  - Pfk
  - Ldh
---
